Rubicon Research Share Price Today (RUBICON)
TODAY IN ONE LINE
RUBICON slipped 0.3% on light volume, in line with Nifty's -0.4% move, supported by recent strong earnings.
With a market cap of ₹25,045.3 Cr., it trades at a P/E of 101.81. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
Rubicon Research flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●Earnings GrowthEPS (TTM) grew by a solid 96.6% YoY
- ●Quarterly OutperformanceLatest quarter Sales up 43.5% and Profit up 112.0%
- ●High Capital EfficiencyROCE of 28.4% indicating pricing power
- ●Strong Return on EquityHealthy ROE of 27.0%
- ●Healthy Operating MarginsOPM is structurally strong at 22.8%
- ●High Promoter HoldingPromoters hold 59.9% skin-in-the-game
- ●Virtually Debt-FreeVery low Debt-to-Equity of 0.00x
Red Flags
- ●Expensive ValuationTrading at a high P/E ratio of 92.0x
- ●Promoter Pledging DetectedPledge activity recorded on 2026-06-30
Latest Rubicon Research News
What changed recently?
Recent events, corporate actions, and announcements.
Rubicon Research Limited valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for Rubicon Research Limited, framed against the sector median so the premium or discount is obvious at a glance.
Rubicon Research Limited trades at a P/E of 101.81× and P/B of 19.50×.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
Rubicon Research Limited technical analysis: indicators, pivots and CPR.
Live RSI, MACD and moving-average signals plus today's pivot and Central Pivot Range levels for Rubicon Research Limited — derived from the live tape, not yesterday's close.
Rubicon Research Limited last traded at ₹1,520.2 with an intraday range of ₹1,489.5–₹1,560 — live indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Live: ₹1520.20| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 1697.97 | +177.77 | +11.69% |
| R3 | 1627.47 | +107.27 | +7.06% |
| R2 | 1593.73 | +73.53 | +4.84% |
| R1 | 1556.97 | +36.77 | +2.42% |
| PIVOT | 1523.23 | 3.03 | 0.20% |
| CURRENT | 1520.20 | — | — |
| S1 | 1486.47 | -33.73 | -2.22% |
| S2 | 1452.73 | -67.47 | -4.44% |
| S3 | 1415.97 | -104.23 | -6.86% |
| S4 | 1345.47 | -174.73 | -11.49% |
RUBICON is trading Below CPR, indicating Bearishness
CPR is Average
Day's range: ₹1525.4–₹1560
Trading Inside opening range
Rubicon Research Limited financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for Rubicon Research Limited — consolidated or standalone — with margins, YoY growth and key ratios inline.
Rubicon Research Limited reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹25,045.3 Cr. and reported EPS of ₹15.48.
| Metric | — | Mar 2026 |
|---|---|---|
| Revenue from Operations | — | 1,754 |
| Other Income | — | 8 |
| Total Income | — | 1,762 |
| — | 556 | |
| Gross ProfitDerived | — | 1,198 |
| Gross Margin %Derived | — | 68.30% |
| — | 798 | |
| EBITDA (Operating Profit)Derived | — | 400 |
| OPM %Derived | — | 22.82% |
| — | 87 | |
| Profit Before Tax (PBT) | — | 321 |
| — | 74 | |
| Effective Tax %Derived | — | 23.02% |
| Total Profit for Period | — | 247 |
| Net Profit (Owner's PAT)Derived | — | 247 |
| Net Profit Margin %Derived | — | 14.07% |
| Earnings Per Share (EPS ₹) | — | 14.95 |
| Diluted Shares Outstanding (Cr) | — | 17 |
| Other Comprehensive Income (Net of Tax) | — | 3 |
| Total Expenses (incl. D&A & Interest) | — | 1,441 |
| Material Cost % of RevenueDerived | — | 35.07% |
| Employee Cost % of RevenueDerived | — | 14.61% |
| Other Cost % of RevenueDerived | — | 30.87% |
| Interest Coverage (x)Derived | — | 8.42x |
| Period | Mar 2026 | Trend |
|---|---|---|
| Revenue from Operations | 1,754 | |
| Other Income | 8 | |
| Total Income | 1,762 | |
556 | ||
| Gross ProfitDerived | 1,198 | |
| Gross Margin %Derived | 68.30% | |
798 | ||
| EBITDA (Operating Profit)Derived | 400 | |
| OPM %Derived | 22.82% | |
87 | ||
| Profit Before Tax (PBT) | 321 | |
74 | ||
| Effective Tax %Derived | 23.02% | |
| Total Profit for Period | 247 | |
| Net Profit (Owner's PAT)Derived | 247 | |
| Net Profit Margin %Derived | 14.07% | |
| Earnings Per Share (EPS ₹) | 14.95 | |
| Diluted Shares Outstanding (Cr) | 17 | |
| Other Comprehensive Income (Net of Tax) | 3 | |
| Total Expenses (incl. D&A & Interest) | 1,441 | |
| Material Cost % of RevenueDerived | 35.07% | |
| Employee Cost % of RevenueDerived | 14.61% | |
| Other Cost % of RevenueDerived | 30.87% | |
| Interest Coverage (x)Derived | 8.42x |
Rubicon Research segment analysis : revenue and profit mix.
Disclosed business segments at Rubicon Research with their share of revenue and profit, switchable between consolidated and standalone reporting.
Rubicon Research discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for Rubicon Research Limited.
Our AI distills the core fundamental drivers supporting Rubicon Research Limited, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
Rubicon Research Limited's investment case rests on 10 positive markers and 10 flagged concerns drawn from the latest reported filings.
What you're getting.
Latest quarterly EPS grew 111.9% YoY, demonstrating exceptional earnings acceleration.
TTM EPS grew 96.6% YoY, sustaining strong profit momentum across reporting periods.
ROE of 27.00% and ROCE of 28.40% significantly exceed typical pharma sector averages.
Operating margin of 20.24% reflects robust pricing power and operational excellence.
Promoter holding of 59.86% ensures stable, long-term strategic ownership commitment.
Key Risks.
P/E ratio of 92.04x represents extreme valuation premium, limiting upside potential.
Zero dividend yield offers no income to shareholders despite strong profitability.
EV/EBITDA of 33.21x trades at significant premium to sector peers and norms.
Operating cash flow conversion of 20.6% vs net profit signals working capital drag.
Heavy capex of ₹217.08 Cr in Q2 FY2026 strains free cash flow generation capacity.
Flip Conditions.
Valuation risk. a P/E above 132 would leave less room for earnings disappointment.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 1.00. Balance sheet risk re-prices growth multiples fast.
Return-quality risk. ROE below 22% would indicate weaker capital compounding.
Rubicon Research Limited peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — Rubicon Research Limited is highlighted for quick read-across.
Quick Compare
Peer Comparison
| Company Name |
|---|
Rubicon Research Limited chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for Rubicon Research Limited — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
- 1Pick how to scan. Detection sets sensitivity — Daily (standard) → Weekly (big swings). History sets how far back to look.
- 2Read the summary. The tiles at the top give the current read: net bias, the strongest pattern, and the one nearest to triggering.
- 3Scan the list. Use the Actionable, Watchlist, and History tabs to browse patterns. Click a pattern card to focus it.
- 4Inspect on the chart. Focusing draws the pattern’s pivots plus its break (blue), target (amber) and invalidation lines.
- 5Filter to what matters. Use the status controls (Confirmed, Forming, Invalidated) to hide noise and find exactly what you are looking for.
Pattern history — every completed pattern and its outcome
Rubicon Research Limited delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for Rubicon Research Limited over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in Rubicon Research Limited stood at 31.3% of traded volume, against a 20-day average of 45.4%.
Rubicon Research announcements: results, concalls, ratings, M&A.
Filings Rubicon Research sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
Rubicon Research files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 50 documents below.
Updates
Rubicon Research Limited has informed the Exchange regarding 'Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations,…
General Updates
Rubicon Research Limited has informed the Exchange about General Updates
Trading Window
Rubicon Research Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading)…
Disclosure under SEBI Takeover Regulations
Rubicon Research Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) read with Regulation 31(5) of SEBI (Substantial…
Disclosure under SEBI Takeover Regulations
Rubicon Research Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India…
Investor decks & rating reports.
Rubicon Research dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue Rubicon Research has declared, sequenced by announce and record date.
Rubicon Research corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About Rubicon Research Limited: business, sector, key facts.
What Rubicon Research Limited does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
Rubicon Research Limited operates in the Pharmaceuticals industry under the Healthcare sector.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- 3B Blackbio DX (3BBLACKBIO) Share PricePeer
- Abbott India (ABBOTINDIA) Share PricePeer
- Acutaas Chemicals (ACUTAAS) Share PricePeer
- Anlon Healthcare (AHCL) Share PricePeer
- Amanta Healthcare (AMANTA) Share PricePeer
- Stocks near 52-week high (breakout watch)Screener
- Breakout Trader strategy playbookStrategy
- Other overvalued NSE stocksScreener
- Top quality scorecard stocksScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy
Questions investors ask about Rubicon Research Limited (RUBICON).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of Rubicon Research Limited (RUBICON)?
The current share price of Rubicon Research Limited (RUBICON) is ₹1,520.2. Today, the stock has declined by ₹5.20 (0.34%), trading in a range of ₹1,489.5 to ₹1,560. The stock opened at ₹1,529.7 with a trading volume of 1,83,736 shares.
02Is Rubicon Research Limited stock a good investment for long-term?
Rubicon Research Limited can be considered for long-term investment based on several factors. The company has a market capitalization of ₹25,045.3 crores, P/E ratio of 101.81, ROE of 27.00%, and ROCE of 28.40%. The dividend yield stands at 0.00%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of Rubicon Research Limited stock?
The 52-week high price of Rubicon Research Limited (RUBICON) is ₹1,547.3, while the 52-week low is ₹570.75. Currently trading at ₹1,520.2, the stock is 97.2% away from its 52-week low and 1.8% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy Rubicon Research Limited stock at the current price?
Whether to buy Rubicon Research Limited stock at ₹1,520.2 depends on multiple factors. The stock is currently trading with a P/E ratio of 101.81 and P/B ratio of 19.50. Today's performance shows a loss of 0.34%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of Rubicon Research Limited and when is the next dividend?
Rubicon Research Limited offers a dividend yield of 0.00%, which means for every ₹100 invested at the current price of ₹1,520.2, you can expect to receive approximately ₹0.00 annually as dividends. The face value of the stock is ₹1.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of Rubicon Research Limited?
Rubicon Research Limited's key financial metrics include: P/E Ratio: 101.81, P/B Ratio: 19.50, ROE: 27.00%, ROCE: 28.40%, Dividend Yield: 0.00%, EPS: ₹15.48, Book Value: ₹78.22, and Debt-to-Equity: 0.24. The company's market cap stands at ₹25,045.3 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is Rubicon Research Limited stock performing today in the market?
Rubicon Research Limited stock opened at ₹1,529.7 and is currently trading at ₹1,520.2, showing a decline of ₹5.20 (0.34%). The intraday high is ₹1,560 and low is ₹1,489.5. The trading volume stands at 1,83,736 shares, indicating moderate market participation today.
08What is the P/E ratio of Rubicon Research Limited and what does it indicate?
Rubicon Research Limited has a Price-to-Earnings (P/E) ratio of 101.81, which means investors are willing to pay ₹101.81 for every ₹1 of earnings. With an EPS of ₹15.48, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about Rubicon Research Limited (RUBICON) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.